Fan ZC, Sartin JL, and Tao YX. (2008) Pharmacological analyses of two naturally occurring porcine melanocortin-4 receptor mutations in domestic pigs. Domest. Anim. Endocrinol. 34:383-390, 2008.
Fan Z-C, Sartin JL, and Tao Y-X. (2007) Molecular cloning and pharmacological characterization of porcine melanocortin-3 receptor. J Endocrinol 196:139-148
Tao Y-X. (2007) Functional characterization of novel melanocortin-3 receptor mutations identified from obese subjects. Biochimica et Biophysica Acta - Molecular Basis of Disease 1772:1167-1174.
Tao Y-X. 2008. Inactivating melanocortin-4 receptor mutations and human obesity. In Obesity and Energy Metabolism: Research and Clinical Applications, Donohoue PA, Editor. Humana Press, Totowa, NJ. Pages 45-58.
Zhang M, Tao Y-X, Ryan GL, Feng X, Fanelli F and Segaloff DL (2007) Intrinsic differences in the response of the human lutropin receptor versus the human follitropin receptor to activating mutations. J. Biol. Chem. 282(35):25527-25539.
Freitas KCM, Ryan G, Brito VN, Tao Y-X, Costa EMF, Mendonca BB, Segaloff D, and Latronico AC. (2007) Molecular analysis of the neuropeptide Y1 receptor gene in human idiopathic gonadotropin-dependent precocious puberty and isolated hypogonadotropic hypogonadism. Fertility and Sterility 87(3): 627-634.
Tao, Y-X. (2006) Inactivating mutations of G protein-coupled receptors and diseases: Structure-function insights and therapeutic implications. Pharmacology and Therapeutics 111:949-973.
Rong R, Tao Y-X, Cheung BMY, Xu A, Cheung GCN and Lam KSL (2006) Identification and functional characterization of three novel human melanocortin-4 receptor gene variants in an obese Chinese population. Clin Endocrinol 65:198-205.
Tao, Y-X and Segaloff DL. (2005) Functional analyses of melanocortin-4 receptor mutations identified from patients with binge eating disorder and non-obese or obese subjects. J Clin Endocrinol Metab 90:5632-5638.
Tao Y-X. (2005) Molecular mechanisms of the neural melanocortin receptor dysfunction in severe early-onset obesity. Mol Cell Endocrinol 239:1-14.
Tao Y-X and Segaloff DL. (2004) Functional characterization of melanocortin-3 receptor variants identify a loss-of-function mutation involving an amino acid critical for G protein-coupled receptor activation. J Clin Endocrinol Metab 89:3936-3942.
Tao Y-X, Johnson NB and Segaloff DL. (2004) Constitutive and agonist-dependent self-association of the cell surface human lutropin receptor. J Biol Chem 279:5904-5914.
Donohoue PA, Tao Y-X, Collins M, Yeo GSH, O’Rahilly S and Segaloff DL. (2003) Deletion of codons 88-92 of the melanocortin-4 receptor gene: a novel deleterious mutation in an obese female. J Clin Endocrinol Metab 88:5841-5845.
Tao Y-X and Segaloff DL. (2003) Functional characterization of human melanocortin-4 receptor mutations associated with childhood obesity. Endocrinology 144:4544-4551.
Shinozaki H, Butnev V, Tao Y-X, Ang KL, Conti M and Segaloff DL. (2003) Desensitization of Gs-coupled receptor signaling by constitutively active mutants of the human lutropin/choriogonadotropin receptor. J Clin Endocrinol Metab 88:1194-1204.
Tao Y-X, Mizrachi D and Segaloff DL. (2002) Chimeras of the rat and human FSH receptors (FSHRs) identify residues that permit or suppress transmembrane 6 mutation-induced constitutive activation of the FSHR via rearrangements of hydrophobic interactions between helices 6 and 7. Mol Endocrinol 16:1881-1892.
Tao Y-X, Abell AN, Liu X, Nakamura K and Segaloff DL. (2000) Constitutive activation of G protein-coupled receptors as a result of substitution of a conserved leucine residue in transmembrane helix III. Mol Endocrinol 14:1272-1282.